Showing results (1-10 of 147) with videos related to
Sort By:
Pageof 15
Iranian Journal of Pharmaceutical Research : IJPR|July 23, 2026
In silico Identification of Natural Compounds as Potential TrkA Inhibitors for Anticancer Drug DevelopmentMujtaba Fadhil, Dhurgham Al-Fahad, Faizul Azam, et al.Journal of Biomolecular Structure & Dynamics|August 11, 2023
Identification of potential inhibitors of HER2 targeting breast cancer-a structure-based drug design approachGagandeep Singh, Dhurgham Al-Fahad, Mrtatha K Al-Zrkani, et al.Biochemistry and Biophysics Reports|November 5, 2024
An in-silico approach to target multiple proteins involved in anti-microbial resistance using natural compounds produced by wild mushroomsGagandeep Singh, Md Alamgir Hossain, Dhurgham Al-Fahad, et al.Antibiotics (Basel, Switzerland)|August 6, 2021
Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19Faizul AzamReports of Biochemistry & Molecular Biology|October 4, 2021
Roles of Endocytic Processes and Early Endosomes on Focal Adhesion Dynamics in MDA-MB-231 CellsBandar Fahad Alharbi, Dhurgham Al-Fahad, Philip Richard DashReports of Biochemistry & Molecular Biology|September 27, 2022
Regulation of Focal Adhesion Dynamics and Cell Migration by PLC/PI3K-Mediated Metabolism of PtdIns (4,5) P2 in a Breast Cancer Cell LineDhurgham Al-Fahad, Firas Alyaseen, Ahmed Al-Amery, et al.Reports of Biochemistry & Molecular Biology|March 16, 2022
A Comparative Study to Visualize PtdIns(4,5) P2 and PtdIns(3,4,5) P3 in MDA-MB-231 Breast Cancer Cell LineDhurgham Al-Fahad, Bandar Al-Harbi, Yahya Abbas, et al.Molecules (Basel, Switzerland)|September 23, 2022
Microsecond MD Simulations to Explore the Structural and Energetic Differences between the Human RXRα-PPARγ vs. RXRα-PPARγ-DNAFaizul Azam, Martiniano BelloRSC Advances|December 22, 2022
Dynamic and thermodynamic impact of L94A, W100A, and W100L mutations on the D2 dopamine receptor bound to risperidoneFaizul Azam, Martiniano BelloInternational Journal of Molecular Sciences|April 14, 2026
Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and OpportunitiesFaizul Azam, Suliman A AlmahmoudPageof 15